Papers
5
Total Citations
212
H-Index
5
About
Ana Gleisner is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques in complex hepato-pancreato-biliary (HPB) and gastrointestinal surgeries. Her major contributions center on rigorously comparing the short-term and oncologic outcomes of minimally invasive versus open procedures for pancreatic, esophageal, and rectal cancers. In her landmark 2018 study (159 citations), she analyzed the National Cancer Database to demonstrate that minimally invasive pancreaticoduodenectomy (MIPD) yields comparable oncologic results to open surgery, particularly in high-volume centers. Gleisner has also critically examined the implications of conversion to open surgery during minimally invasive esophagectomy, showing that such conversions portend worse short-term outcomes. Her work on rectal cancer surgery (21 citations) further underscores the benefits of laparoscopic and robotic approaches. Beyond clinical outcomes, Gleisner addresses systemic barriers to adoption and equitable access to advanced HPB surgery, advocating for broader implementation of these techniques. Her research has been instrumental in shaping evidence-based guidelines for minimally invasive cancer surgery, making her a key voice in the ongoing effort to improve surgical care and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5